TB
The startup designs automated processing lines for the recycling of human tissue, specifically focusing on the production of bone allografts. Their technology enables the repair, replacement, and regeneration of human tissues, providing measurable clinical benefits that enhance patient health and longevity.
Updated 3 months ago
Funding
$570K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup designs automated processing lines for the recycling of human tissue, specifically focusing on the production of bone allografts. Their technology enables the repair, replacement, and regeneration of human tissues, providing measurable clinical benefits that enhance patient health and longevity.